APP and Alzheimer disease: Moreover, OPA1 overexpression or activation improved cognitive function, synaptic plasticity, and synaptic transmission efficiency in APP/PS1 mice, suggesting that OPA1 activation may represent a promising therapeutic direction for AD treatment.